SCHEMBL9789782

SCHEMBL9789782

CC(C)(C)Oc1cc(O)cc(OC(C)(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
BACE1 P56817 1/20 0.37
ALDH1A1 P00352 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KIF11 P52732 1/20 0.34
CYP3A4 P08684 3/20 0.33
MAPT P10636 2/20 0.33
TP53 P04637 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LCK P06239 1/20 0.33
TTR P02766 1/20 0.33
CYP1A1 P04798 1/20 0.33
ALOX5 P09917 1/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13449766 0.94 BACE1 (0.44) GABRA1GABRB2BACE1ALDH1A1TDP1
SCHEMBL18925849 0.93 HSP90AA1 (0.41) GABRA1GABRB2BACE1ALDH1A1TDP1
SCHEMBL3818720 0.88 ALDH1A1 (0.39) ALDH1A1KIF11ABL1
SCHEMBL20130330 0.85 ALDH1A1 (0.52) GABRA1GABRB2BACE1ALDH1A1TDP1
SCHEMBL15934242 0.84 GABRA1 (0.34) GABRA1GABRB2ALDH1A1TDP1CA1
SCHEMBL14805919 0.83 TTR (0.41) GABRA1GABRB2CA2MEN1KMT2A
SCHEMBL15934277 0.80 LMNA (0.32) GABRA1GABRB2ALDH1A1CYP3A4TP53
SCHEMBL18925848 0.80 KIF11 (0.35) ALDH1A1KIF11MAPTSMN1; SMN2NPC1
SCHEMBL14075676 0.78 ALDH1A1 (0.61) ALDH1A1CA1CA2CYP3A4TTR
SCHEMBL15341308 0.78 ALDH1A1 (0.37) ALDH1A1TDP1CA2KIF11CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504380-A Liquid stabilizer for nitrate compound and preparation method thereof 南京理工大学 2025-02-25 CN disclosed
US-10272079-B2 NHE3-binding compounds and methods for inhibiting phosphate transport ARDELYX, INC. (US) 2019-04-30 US disclosed
US-20160067242-A1 NHE3-BINDING COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. 2016-03-10 US disclosed
US-5072034-A PREPARATION OF 4-ALKOXY-2-HYDROXYBENZOPHENONE-5-SULFONIC ACIDS BASF AKTIENGESELLSCHAFT (DE) 1991-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160067242-A1 NHE3-BINDING COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT SLC34A3, SLC34A2, SLC34A1 GABRA1 3559/4885GABRB2 2465/4885BACE1 4681/4885
US-10272079-B2 NHE3-binding compounds and methods for inhibiting phosphate transport SLC34A3, SLC34A2, SLC34A1 GABRA1 3559/4885GABRB2 2465/4885BACE1 4681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.